Search the Archive

Experimental Drug Controversy #306845

CBS Evening News for Tuesday, Oct 14, 1986
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Dan Rather) Report introduced.

(Boston, Massachusetts: Steve Young) Impact on victims of eye disorder of halt to manufacturer of experimental drug Oculinum due to manufacturer's inability to get liability insurance examined; details given, scenes shown. [Mary SOUSA - recalls effect of drug on her, problems since manufacturer was halted.] [Dr. Gary BORODIC - notes scope of suffering due to drug's lack of availability now.] [Dr. Edward SCHANTZ - notes safety factor involved.] [Dr. Daniel TOWNSEND - comments.] Current plights of victims Rita Bannister and Dr. Thomas Crowe described. FDA's response mentioned.

Reporter(s):
Rather, Dan;
Young, Steve
Duration:
00:02:10

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.